Anaptysbio (ANAB) Capital Expenditures (2016 - 2026)
Anaptysbio (ANAB) posted Capital Expenditures of $17000.0 for Q1 2026, down 80.46% on a QoQ basis from $87000.0 in Q4 2025, and up 54.55% year-over-year from $11000.0 in Q1 2025.
Anaptysbio (ANAB) Capital Expenditures (2016 - 2026) Analysis & Trends
Anaptysbio's Capital Expenditures history runs 11 years deep, the most recent figure standing at $17000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 54.55% year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93000.0 (up 1133.33% YoY) and the FY2025 annual result came in at $87000.0, up 1142.86% from the prior year.
- Capital Expenditures was $17000.0 for Q1 2026 at Anaptysbio, down from $87000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $280000.0 in Q4 2023 and bottomed at -$74000.0 in Q3 2025.
- A 5-year average of $63058.8 and a median of $33000.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures slumped 134.57% — and 2025, when it jumped 2800.0%.
- Anaptysbio's Capital Expenditures stood at $126000.0 in 2022, then surged by 122.22% to $280000.0 in 2023, then sank by 98.93% to $3000.0 in 2024, then soared by 2800.0% to $87000.0 in 2025, then plunged by 80.46% to $17000.0 in 2026.
- Business Quant data shows ANAB's Capital Expenditures at $17000.0 in Q1 2026, $87000.0 in Q4 2025, and -$74000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 87,000.00 |
| Dec 31, 2025 | 87,000.00 |
| Sep 30, 2025 | -74,000.00 |
| Sep 30, 2025 | -74,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | -56,000.00 |
| Sep 30, 2024 | -56,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 280,000.00 |
| Dec 31, 2023 | 280,000.00 |